
    
      This multicenter prospective patient registry was developed with the aim of documenting how
      spine and neurosurgeons are utilizing the NanoBone products along with relevant patient
      outcomes. These outcomes include radiographic measures such as fusion outcome,
      instrumentation integrity, and clinical outcomes (symptom and function improvement) based on
      investigator and patient-based outcome assessments.

      The primary objective of this study is to document and analyze the use of NanoBone products
      in spine fusion surgery (as a stand-alone bone graft, or in combination with local bone only,
      no other BGS or biologic product used) and determine both radiographic success and clinical
      outcomes. All product related adverse events will be documented, tabulated, and summarized.
    
  